SCHEMBL8868686

SCHEMBL8868686

COCCNC(=O)c1ccc(C(=O)NS(=O)(=O)c2cccc(CCNC(=O)CC3CCCCC3)c2)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.44
LMNA P02545 4/20 0.42
MAPT P10636 3/20 0.42
CYP3A4 P08684 3/20 0.42
CYP2C9 P11712 3/20 0.42
CYP2C19 P33261 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TSHR P16473 2/20 0.42
BLM P54132 2/20 0.42
HTR1A P08908 1/20 0.42
NFKB1 P19838 1/20 0.42
CNR1 P21554 1/20 0.42
ADRA1A P35348 1/20 0.42
P4HTM Q9NXG6 2/20 0.39
ALDH1A1 P00352 3/20 0.39
NAMPT P43490 1/20 0.39
KMT2A Q03164 2/20 0.38
HIF1A Q16665 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868623 0.92 EPHX2 (0.47) EPHX2LMNAMAPTCYP3A4CYP2C9
SCHEMBL8869358 0.92 EPHX2 (0.43) EPHX2LMNAMAPTCYP3A4CYP2C9
SCHEMBL9139947 0.91 EPHX2 (0.46) EPHX2LMNAMAPTCYP3A4CYP2C9
SCHEMBL8869510 0.91 LMNA (0.52) EPHX2LMNAMAPTCYP3A4CYP2C9
SCHEMBL8869208 0.89 MAPT (0.45) EPHX2LMNAMAPTCYP3A4CYP2C9
SCHEMBL9139607 0.89 P4HTM (0.53) EPHX2LMNAMAPTCYP3A4CYP2C9
SCHEMBL7862673 0.89 EPHX2 (0.44) EPHX2LMNAMAPTCYP3A4CYP2C9
SCHEMBL8869596 0.86 CA1 (0.43) LMNAMAPTSMN1; SMN2P4HTMALDH1A1
SCHEMBL8869814 0.86 P4HTM (0.48) LMNAMAPTSMN1; SMN2P4HTMALDH1A1
SCHEMBL8869241 0.85 P4HTM (0.46) LMNAMAPTSMN1; SMN2P4HTMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed